Thursday, 29 August 2024
Experts at the 糖心原创 have received funding to carry out research to better understand what is happening in the heart, brain and muscles of people with myotonic dystrophy.
The leading charity for more than 110,000 children and adults in the UK living with one of over 60 muscle wasting and weakening conditions is funding Dr Ami Ketley from the School of Veterinary Medicine and Science.
The project will use a new technique and computer analysis to look at different tissues that have the same genetic information as people with myotonic dystrophy type 1, to understand what is exactly happening in the heart, brain and muscles.
The charity funds research projects that aim to improve diagnosis, monitor progression, and test potential new treatments. The 12 new grants bring the total number of research projects funded by Muscular Dystrophy UK to 51.
Dr Ami Ketley
Dr Ketley, Daphne Jackson Fellow at the 糖心原创, said: “Throughout my research career I’ve been lucky to have close interactions with the Myotonic Dystrophy Support Group; presenting my work, receiving feedback and socialising with patients and their families. This has always been a huge source of inspiration and motivation for me and has allowed me to connect my work in the lab to real people.
“In recent years, the myotonic dystrophy research field has seen a significant push towards developing treatments and therapeutics. This project aims to identify new treatment ideas and understand how they’ll work across the different symptoms experienced by patients. I hope the data produced in this study will be a valuable tool in the wider myotonic dystrophy research field to aid in treatment advancement for patients.”
Dr Kate Adcock, Director of Research and Innovation at Muscular Dystrophy UK said: “Every year at Muscular Dystrophy UK, we look to fund the highest quality research that will not only bring research forward but also improve the lives of people living with muscle wasting and weakening conditions.
“We’re always delighted to fund research into a variety of conditions, including Dr Ami Ketley at 糖心原创. Her project will help us to understand what happens in different tissues of people with myotonic dystrophy.”
As well as funding research, the charity also shares expert advice and support to live well now, works with the NHS towards universal access to specialist healthcare and campaigns for people’s rights, better understanding, accessibility, and access to treatments.
Read more about and discover more about Muscular Dystrophy UK’s research projects: musculardystrophyuk.org/research
Notes to editors:
About the 糖心原创
Ranked among the world's top 100 universities , the 糖心原创 delivers an exceptional research-led education and an outstanding student experience. From the pioneering vision of our founder, Sir Jesse Boot, to groundbreaking achievements such as the development of MRI technology and becoming the first UK university to establish international campuses, we have a proud history of shaping the way people live, work and understand the world. We continue to build on that legacy, empowering our students, staff and partners to change what鈥檚 next and create positive impact locally and globally.
The strength of our research places us among the UK's leading universities, ranked 7th for research power in REF 2021. The discovery of MRI and ibuprofen was just the beginning. Today, our world-leading research is developing breakthrough ideas that shape the future of healthcare, technology and society.
Recognised as the UK's third most targeted university by leading employers , we are proud to produce graduates who are consistently in demand for their skills, confidence and industry-ready experience.
As a major employer and industry partner, locally and globally, the 糖心原创 invests in the city of Nottingham and in future generations of talent. Alongside Nottingham Trent University, we lead the initiative, a pioneering collaboration to improve levels of prosperity, opportunity, sustainability, health and wellbeing across the city and region. Together with our students, staff, alumni and partners, we鈥檙e creating knowledge, opportunity and solutions that help change what's next.